nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—HTR7—Parkinson's disease	0.2	0.262	CbGaD
Maprotiline—SLC6A3—Parkinson's disease	0.175	0.229	CbGaD
Maprotiline—DRD2—Parkinson's disease	0.13	0.17	CbGaD
Maprotiline—HTR2A—Parkinson's disease	0.1	0.132	CbGaD
Maprotiline—CYP2D6—Parkinson's disease	0.0917	0.12	CbGaD
Maprotiline—ABCB1—Parkinson's disease	0.0655	0.086	CbGaD
Maprotiline—HTR7—enteric nervous system—Parkinson's disease	0.00557	0.055	CbGeAlD
Maprotiline—HTR7—superior cervical ganglion—Parkinson's disease	0.00533	0.0526	CbGeAlD
Maprotiline—HTR7—myenteric nerve plexus—Parkinson's disease	0.00422	0.0417	CbGeAlD
Maprotiline—SLC6A2—locus ceruleus—Parkinson's disease	0.00382	0.0377	CbGeAlD
Maprotiline—HTR7—locus ceruleus—Parkinson's disease	0.00368	0.0363	CbGeAlD
Maprotiline—HTR2A—enteric nervous system—Parkinson's disease	0.00347	0.0343	CbGeAlD
Maprotiline—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00302	0.0298	CbGeAlD
Maprotiline—HTR7—sympathetic nervous system—Parkinson's disease	0.00291	0.0287	CbGeAlD
Maprotiline—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00263	0.026	CbGeAlD
Maprotiline—HTR2A—locus ceruleus—Parkinson's disease	0.00229	0.0226	CbGeAlD
Maprotiline—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00224	0.0221	CbGeAlD
Maprotiline—HTR2C—telencephalic ventricle—Parkinson's disease	0.00217	0.0214	CbGeAlD
Maprotiline—HTR7—pons—Parkinson's disease	0.00212	0.0209	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—Parkinson's disease	0.00203	0.02	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—Parkinson's disease	0.00195	0.0193	CbGeAlD
Maprotiline—HTR2A—cerebellar cortex—Parkinson's disease	0.00187	0.0184	CbGeAlD
Maprotiline—HTR2A—sympathetic nervous system—Parkinson's disease	0.00181	0.0179	CbGeAlD
Maprotiline—HTR7—telencephalic ventricle—Parkinson's disease	0.00174	0.0172	CbGeAlD
Maprotiline—DRD2—telencephalic ventricle—Parkinson's disease	0.00165	0.0163	CbGeAlD
Maprotiline—SLC6A3—nerve—Parkinson's disease	0.00141	0.0139	CbGeAlD
Maprotiline—HTR7—peripheral nervous system—Parkinson's disease	0.00141	0.0139	CbGeAlD
Maprotiline—HTR2A—pons—Parkinson's disease	0.00132	0.013	CbGeAlD
Maprotiline—Sertraline—MAOB—Parkinson's disease	0.00129	0.199	CrCbGaD
Maprotiline—HTR2A—autonomic nervous system—Parkinson's disease	0.00122	0.012	CbGeAlD
Maprotiline—SLC6A2—nerve—Parkinson's disease	0.00114	0.0113	CbGeAlD
Maprotiline—HTR7—nerve—Parkinson's disease	0.0011	0.0108	CbGeAlD
Maprotiline—HTR2A—telencephalic ventricle—Parkinson's disease	0.00109	0.0107	CbGeAlD
Maprotiline—SLC6A3—hindbrain—Parkinson's disease	0.00106	0.0104	CbGeAlD
Maprotiline—DRD2—nerve—Parkinson's disease	0.00104	0.0103	CbGeAlD
Maprotiline—Sertraline—MAOA—Parkinson's disease	0.000907	0.14	CrCbGaD
Maprotiline—HTR2A—peripheral nervous system—Parkinson's disease	0.000879	0.00868	CbGeAlD
Maprotiline—HTR7—hindbrain—Parkinson's disease	0.000823	0.00812	CbGeAlD
Maprotiline—Sertraline—SLC6A3—Parkinson's disease	0.000782	0.12	CrCbGaD
Maprotiline—DRD2—hindbrain—Parkinson's disease	0.000778	0.00768	CbGeAlD
Maprotiline—HTR2A—nerve—Parkinson's disease	0.000685	0.00676	CbGeAlD
Maprotiline—CHRM4—head—Parkinson's disease	0.000627	0.00619	CbGeAlD
Maprotiline—SLC6A3—brainstem—Parkinson's disease	0.000607	0.00599	CbGeAlD
Maprotiline—CHRM4—nervous system—Parkinson's disease	0.000594	0.00586	CbGeAlD
Maprotiline—CHRM2—forebrain—Parkinson's disease	0.000587	0.0058	CbGeAlD
Maprotiline—HTR2C—brainstem—Parkinson's disease	0.000587	0.00579	CbGeAlD
Maprotiline—SLC6A3—forebrain—Parkinson's disease	0.000586	0.00578	CbGeAlD
Maprotiline—CHRM4—central nervous system—Parkinson's disease	0.000572	0.00565	CbGeAlD
Maprotiline—HTR2C—forebrain—Parkinson's disease	0.000566	0.00559	CbGeAlD
Maprotiline—CHRM1—forebrain—Parkinson's disease	0.000535	0.00528	CbGeAlD
Maprotiline—HTR2A—hindbrain—Parkinson's disease	0.000513	0.00507	CbGeAlD
Maprotiline—CHRM2—cardiovascular system—Parkinson's disease	0.000497	0.0049	CbGeAlD
Maprotiline—CHRM5—head—Parkinson's disease	0.00049	0.00483	CbGeAlD
Maprotiline—SLC6A2—brainstem—Parkinson's disease	0.00049	0.00483	CbGeAlD
Maprotiline—CHRM3—forebrain—Parkinson's disease	0.000478	0.00472	CbGeAlD
Maprotiline—SLC6A2—forebrain—Parkinson's disease	0.000472	0.00466	CbGeAlD
Maprotiline—HTR7—brainstem—Parkinson's disease	0.000472	0.00466	CbGeAlD
Maprotiline—CYP2D6—hindbrain—Parkinson's disease	0.000468	0.00461	CbGeAlD
Maprotiline—CHRM5—nervous system—Parkinson's disease	0.000464	0.00458	CbGeAlD
Maprotiline—HTR7—forebrain—Parkinson's disease	0.000455	0.00449	CbGeAlD
Maprotiline—CHRM4—brain—Parkinson's disease	0.000454	0.00448	CbGeAlD
Maprotiline—CHRM1—cardiovascular system—Parkinson's disease	0.000452	0.00446	CbGeAlD
Maprotiline—CHRM5—central nervous system—Parkinson's disease	0.000447	0.00441	CbGeAlD
Maprotiline—DRD2—brainstem—Parkinson's disease	0.000446	0.0044	CbGeAlD
Maprotiline—DRD2—forebrain—Parkinson's disease	0.000431	0.00425	CbGeAlD
Maprotiline—Sertraline—CYP2D6—Parkinson's disease	0.000411	0.0633	CrCbGaD
Maprotiline—HTR2C—medulla oblongata—Parkinson's disease	0.000409	0.00404	CbGeAlD
Maprotiline—ORM1—spinal cord—Parkinson's disease	0.000406	0.004	CbGeAlD
Maprotiline—SLC6A3—midbrain—Parkinson's disease	0.000387	0.00382	CbGeAlD
Maprotiline—HTR7—cardiovascular system—Parkinson's disease	0.000385	0.0038	CbGeAlD
Maprotiline—SLC6A3—spinal cord—Parkinson's disease	0.000377	0.00372	CbGeAlD
Maprotiline—HTR2C—midbrain—Parkinson's disease	0.000374	0.00369	CbGeAlD
Maprotiline—HTR2C—spinal cord—Parkinson's disease	0.000365	0.0036	CbGeAlD
Maprotiline—CHRM5—brain—Parkinson's disease	0.000355	0.0035	CbGeAlD
Maprotiline—ORM1—nervous system—Parkinson's disease	0.000342	0.00337	CbGeAlD
Maprotiline—SLC6A2—medulla oblongata—Parkinson's disease	0.000341	0.00337	CbGeAlD
Maprotiline—HRH1—forebrain—Parkinson's disease	0.00034	0.00336	CbGeAlD
Maprotiline—CHRM2—head—Parkinson's disease	0.000336	0.00332	CbGeAlD
Maprotiline—SLC6A3—head—Parkinson's disease	0.000335	0.00331	CbGeAlD
Maprotiline—ORM1—central nervous system—Parkinson's disease	0.000329	0.00325	CbGeAlD
Maprotiline—HTR7—medulla oblongata—Parkinson's disease	0.000329	0.00325	CbGeAlD
Maprotiline—HTR2C—head—Parkinson's disease	0.000324	0.0032	CbGeAlD
Maprotiline—HTR2A—embryo—Parkinson's disease	0.000321	0.00317	CbGeAlD
Maprotiline—CHRM2—nervous system—Parkinson's disease	0.000319	0.00315	CbGeAlD
Maprotiline—SLC6A3—nervous system—Parkinson's disease	0.000318	0.00314	CbGeAlD
Maprotiline—HTR2C—nervous system—Parkinson's disease	0.000307	0.00303	CbGeAlD
Maprotiline—CHRM2—central nervous system—Parkinson's disease	0.000307	0.00303	CbGeAlD
Maprotiline—CHRM1—head—Parkinson's disease	0.000306	0.00302	CbGeAlD
Maprotiline—SLC6A3—central nervous system—Parkinson's disease	0.000306	0.00302	CbGeAlD
Maprotiline—HTR7—midbrain—Parkinson's disease	0.000301	0.00297	CbGeAlD
Maprotiline—SLC6A3—cerebellum—Parkinson's disease	0.000299	0.00295	CbGeAlD
Maprotiline—HTR2C—central nervous system—Parkinson's disease	0.000296	0.00292	CbGeAlD
Maprotiline—HTR2A—brainstem—Parkinson's disease	0.000294	0.0029	CbGeAlD
Maprotiline—Sertraline—ABCB1—Parkinson's disease	0.000294	0.0452	CrCbGaD
Maprotiline—HTR7—spinal cord—Parkinson's disease	0.000293	0.0029	CbGeAlD
Maprotiline—CHRM1—nervous system—Parkinson's disease	0.00029	0.00286	CbGeAlD
Maprotiline—DRD2—midbrain—Parkinson's disease	0.000284	0.00281	CbGeAlD
Maprotiline—HTR2A—forebrain—Parkinson's disease	0.000284	0.0028	CbGeAlD
Maprotiline—CHRM1—central nervous system—Parkinson's disease	0.000279	0.00276	CbGeAlD
Maprotiline—CHRM3—head—Parkinson's disease	0.000274	0.0027	CbGeAlD
Maprotiline—SLC6A2—head—Parkinson's disease	0.000271	0.00267	CbGeAlD
Maprotiline—CYP2D6—brainstem—Parkinson's disease	0.000268	0.00265	CbGeAlD
Maprotiline—HTR7—head—Parkinson's disease	0.000261	0.00257	CbGeAlD
Maprotiline—CHRM3—nervous system—Parkinson's disease	0.00026	0.00256	CbGeAlD
Maprotiline—CYP2D6—forebrain—Parkinson's disease	0.000259	0.00255	CbGeAlD
Maprotiline—SLC6A2—nervous system—Parkinson's disease	0.000256	0.00253	CbGeAlD
Maprotiline—CHRM3—central nervous system—Parkinson's disease	0.00025	0.00247	CbGeAlD
Maprotiline—HTR7—nervous system—Parkinson's disease	0.000247	0.00244	CbGeAlD
Maprotiline—SLC6A2—central nervous system—Parkinson's disease	0.000247	0.00244	CbGeAlD
Maprotiline—DRD2—head—Parkinson's disease	0.000247	0.00243	CbGeAlD
Maprotiline—CHRM2—brain—Parkinson's disease	0.000244	0.0024	CbGeAlD
Maprotiline—SLC6A3—brain—Parkinson's disease	0.000243	0.0024	CbGeAlD
Maprotiline—HTR2A—cardiovascular system—Parkinson's disease	0.00024	0.00237	CbGeAlD
Maprotiline—HTR7—central nervous system—Parkinson's disease	0.000238	0.00235	CbGeAlD
Maprotiline—Protriptyline—CYP2D6—Parkinson's disease	0.000236	0.0364	CrCbGaD
Maprotiline—HTR2C—brain—Parkinson's disease	0.000235	0.00232	CbGeAlD
Maprotiline—DRD2—nervous system—Parkinson's disease	0.000234	0.00231	CbGeAlD
Maprotiline—HTR7—cerebellum—Parkinson's disease	0.000233	0.0023	CbGeAlD
Maprotiline—DRD2—central nervous system—Parkinson's disease	0.000225	0.00222	CbGeAlD
Maprotiline—CHRM1—brain—Parkinson's disease	0.000222	0.00219	CbGeAlD
Maprotiline—DRD2—cerebellum—Parkinson's disease	0.00022	0.00217	CbGeAlD
Maprotiline—ABCB1—embryo—Parkinson's disease	0.00021	0.00208	CbGeAlD
Maprotiline—HTR2A—medulla oblongata—Parkinson's disease	0.000205	0.00202	CbGeAlD
Maprotiline—CHRM3—brain—Parkinson's disease	0.000199	0.00196	CbGeAlD
Maprotiline—Atomoxetine—SLC6A3—Parkinson's disease	0.000197	0.0303	CrCbGaD
Maprotiline—SLC6A2—brain—Parkinson's disease	0.000196	0.00193	CbGeAlD
Maprotiline—HRH1—head—Parkinson's disease	0.000195	0.00192	CbGeAlD
Maprotiline—HTR7—brain—Parkinson's disease	0.000189	0.00186	CbGeAlD
Maprotiline—HTR2A—midbrain—Parkinson's disease	0.000188	0.00185	CbGeAlD
Maprotiline—ABCB1—forebrain—Parkinson's disease	0.000186	0.00184	CbGeAlD
Maprotiline—HRH1—nervous system—Parkinson's disease	0.000185	0.00182	CbGeAlD
Maprotiline—HTR2A—spinal cord—Parkinson's disease	0.000183	0.00181	CbGeAlD
Maprotiline—DRD2—brain—Parkinson's disease	0.000179	0.00176	CbGeAlD
Maprotiline—HRH1—central nervous system—Parkinson's disease	0.000178	0.00175	CbGeAlD
Maprotiline—Protriptyline—ABCB1—Parkinson's disease	0.000169	0.026	CrCbGaD
Maprotiline—HTR2A—head—Parkinson's disease	0.000163	0.0016	CbGeAlD
Maprotiline—ABCB1—cardiovascular system—Parkinson's disease	0.000157	0.00155	CbGeAlD
Maprotiline—HTR2A—nervous system—Parkinson's disease	0.000154	0.00152	CbGeAlD
Maprotiline—Nortriptyline—HTR1A—Parkinson's disease	0.000151	0.0232	CrCbGaD
Maprotiline—HTR2A—central nervous system—Parkinson's disease	0.000148	0.00146	CbGeAlD
Maprotiline—CYP2D6—head—Parkinson's disease	0.000148	0.00146	CbGeAlD
Maprotiline—HTR2A—cerebellum—Parkinson's disease	0.000145	0.00143	CbGeAlD
Maprotiline—Desipramine—SLC6A3—Parkinson's disease	0.000142	0.0218	CrCbGaD
Maprotiline—HRH1—brain—Parkinson's disease	0.000141	0.00139	CbGeAlD
Maprotiline—CYP2D6—nervous system—Parkinson's disease	0.00014	0.00139	CbGeAlD
Maprotiline—Imipramine—HTR7—Parkinson's disease	0.000137	0.0212	CrCbGaD
Maprotiline—CYP2D6—central nervous system—Parkinson's disease	0.000135	0.00133	CbGeAlD
Maprotiline—ABCB1—medulla oblongata—Parkinson's disease	0.000134	0.00133	CbGeAlD
Maprotiline—CYP2D6—cerebellum—Parkinson's disease	0.000132	0.0013	CbGeAlD
Maprotiline—Nortriptyline—DRD2—Parkinson's disease	0.000128	0.0197	CrCbGaD
Maprotiline—Desipramine—HTR1A—Parkinson's disease	0.000124	0.0191	CrCbGaD
Maprotiline—Nortriptyline—CYP2E1—Parkinson's disease	0.000123	0.019	CrCbGaD
Maprotiline—ABCB1—midbrain—Parkinson's disease	0.000123	0.00121	CbGeAlD
Maprotiline—Imipramine—SLC6A3—Parkinson's disease	0.00012	0.0185	CrCbGaD
Maprotiline—ABCB1—spinal cord—Parkinson's disease	0.00012	0.00118	CbGeAlD
Maprotiline—HTR2A—brain—Parkinson's disease	0.000118	0.00116	CbGeAlD
Maprotiline—Atomoxetine—HTR2A—Parkinson's disease	0.000113	0.0174	CrCbGaD
Maprotiline—CYP2D6—brain—Parkinson's disease	0.000107	0.00106	CbGeAlD
Maprotiline—ABCB1—head—Parkinson's disease	0.000107	0.00105	CbGeAlD
Maprotiline—Desipramine—DRD2—Parkinson's disease	0.000105	0.0162	CrCbGaD
Maprotiline—Imipramine—HTR1A—Parkinson's disease	0.000105	0.0162	CrCbGaD
Maprotiline—Atomoxetine—CYP2D6—Parkinson's disease	0.000104	0.0159	CrCbGaD
Maprotiline—Desipramine—CYP2E1—Parkinson's disease	0.000101	0.0156	CrCbGaD
Maprotiline—ABCB1—nervous system—Parkinson's disease	0.000101	0.000997	CbGeAlD
Maprotiline—Nortriptyline—HTR2A—Parkinson's disease	9.89e-05	0.0152	CrCbGaD
Maprotiline—ABCB1—central nervous system—Parkinson's disease	9.73e-05	0.00096	CbGeAlD
Maprotiline—ABCB1—cerebellum—Parkinson's disease	9.51e-05	0.000938	CbGeAlD
Maprotiline—Nortriptyline—CYP2D6—Parkinson's disease	9.05e-05	0.0139	CrCbGaD
Maprotiline—Imipramine—DRD2—Parkinson's disease	8.94e-05	0.0138	CrCbGaD
Maprotiline—Imipramine—CYP2E1—Parkinson's disease	8.61e-05	0.0133	CrCbGaD
Maprotiline—Desipramine—HTR2A—Parkinson's disease	8.15e-05	0.0125	CrCbGaD
Maprotiline—ABCB1—brain—Parkinson's disease	7.72e-05	0.000762	CbGeAlD
Maprotiline—Desipramine—CYP2D6—Parkinson's disease	7.45e-05	0.0115	CrCbGaD
Maprotiline—Imipramine—HTR2A—Parkinson's disease	6.91e-05	0.0106	CrCbGaD
Maprotiline—Imipramine—CYP2D6—Parkinson's disease	6.32e-05	0.00973	CrCbGaD
Maprotiline—Desipramine—ABCB1—Parkinson's disease	5.32e-05	0.00819	CrCbGaD
Maprotiline—Imipramine—ABCB1—Parkinson's disease	4.51e-05	0.00695	CrCbGaD
Maprotiline—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	1.07e-05	8.16e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IGF2—Parkinson's disease	1.06e-05	8.12e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.06e-05	8.08e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.05e-05	8.06e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.05e-05	8.05e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	1.05e-05	8.03e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—DDC—Parkinson's disease	1.05e-05	8.03e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.04e-05	7.95e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.04e-05	7.93e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	1.03e-05	7.9e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IGF1R—Parkinson's disease	1.03e-05	7.85e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.02e-05	7.8e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—INSR—Parkinson's disease	1.02e-05	7.79e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—INSR—Parkinson's disease	1.01e-05	7.76e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EDN1—Parkinson's disease	1.01e-05	7.76e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—INSR—Parkinson's disease	1.01e-05	7.74e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CYP2E1—Parkinson's disease	1e-05	7.68e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	1e-05	7.67e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—INSR—Parkinson's disease	1e-05	7.66e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—NQO1—Parkinson's disease	9.92e-06	7.6e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTA4—Parkinson's disease	9.9e-06	7.58e-05	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	9.88e-06	7.56e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—FGB—Parkinson's disease	9.79e-06	7.49e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—TH—Parkinson's disease	9.78e-06	7.49e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	9.77e-06	7.48e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	9.74e-06	7.46e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	9.69e-06	7.42e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	9.64e-06	7.38e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—FGB—Parkinson's disease	9.63e-06	7.37e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—FGB—Parkinson's disease	9.61e-06	7.36e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	9.6e-06	7.35e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TAC1—Parkinson's disease	9.59e-06	7.34e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	9.59e-06	7.34e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	9.58e-06	7.34e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—FGB—Parkinson's disease	9.58e-06	7.33e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	9.57e-06	7.33e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	9.56e-06	7.32e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	9.56e-06	7.32e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—FGB—Parkinson's disease	9.55e-06	7.31e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	9.53e-06	7.3e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	9.53e-06	7.29e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	9.5e-06	7.27e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PLA2G6—Parkinson's disease	9.46e-06	7.24e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—FGB—Parkinson's disease	9.46e-06	7.24e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	9.44e-06	7.22e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	9.44e-06	7.22e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TAC1—Parkinson's disease	9.42e-06	7.21e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	9.41e-06	7.2e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DRD1—Parkinson's disease	9.41e-06	7.2e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CYCS—Parkinson's disease	9.39e-06	7.19e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	9.39e-06	7.19e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MAOB—Parkinson's disease	9.37e-06	7.17e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	9.36e-06	7.16e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	9.33e-06	7.15e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	9.33e-06	7.15e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NGF—Parkinson's disease	9.31e-06	7.13e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	9.28e-06	7.1e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	9.27e-06	7.09e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	9.25e-06	7.08e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD1—Parkinson's disease	9.23e-06	7.07e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	9.2e-06	7.05e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	9.18e-06	7.02e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	9.17e-06	7.02e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DRD3—Parkinson's disease	9.11e-06	6.97e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	9.09e-06	6.96e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	8.96e-06	6.86e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD3—Parkinson's disease	8.94e-06	6.85e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	8.92e-06	6.83e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	8.91e-06	6.82e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	8.89e-06	6.8e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—DDC—Parkinson's disease	8.88e-06	6.8e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HTR2A—Parkinson's disease	8.87e-06	6.79e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MAOB—Parkinson's disease	8.83e-06	6.76e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	8.8e-06	6.74e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NGF—Parkinson's disease	8.8e-06	6.73e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	8.51e-06	6.51e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NGF—Parkinson's disease	8.42e-06	6.45e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTA4—Parkinson's disease	8.39e-06	6.42e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	8.37e-06	6.41e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	8.37e-06	6.41e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	8.35e-06	6.39e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	8.32e-06	6.37e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—COMT—Parkinson's disease	8.32e-06	6.37e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	8.3e-06	6.35e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	8.28e-06	6.34e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTP1—Parkinson's disease	8.28e-06	6.34e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MAOA—Parkinson's disease	8.26e-06	6.32e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—APOE—Parkinson's disease	8.24e-06	6.31e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR7—Parkinson's disease	8.24e-06	6.31e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	8.22e-06	6.29e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—HMOX1—Parkinson's disease	8.16e-06	6.25e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	8.11e-06	6.21e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	8.11e-06	6.21e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD2—Parkinson's disease	8.09e-06	6.19e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR7—Parkinson's disease	8.09e-06	6.19e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	8.06e-06	6.17e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	8.06e-06	6.17e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	8.04e-06	6.15e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	8.04e-06	6.15e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	8.02e-06	6.14e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	7.96e-06	6.09e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	7.96e-06	6.09e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ABCB1—Parkinson's disease	7.83e-06	6e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	7.82e-06	5.99e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—APOE—Parkinson's disease	7.79e-06	5.96e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTM1—Parkinson's disease	7.61e-06	5.82e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	7.56e-06	5.79e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	7.55e-06	5.78e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MAOB—Parkinson's disease	7.48e-06	5.73e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	7.47e-06	5.72e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—APOE—Parkinson's disease	7.46e-06	5.71e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GPX1—Parkinson's disease	7.28e-06	5.58e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.12e-06	5.45e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—INS—Parkinson's disease	7.04e-06	5.39e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP2D6—Parkinson's disease	6.96e-06	5.33e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF2—Parkinson's disease	6.9e-06	5.28e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NGF—Parkinson's disease	6.87e-06	5.26e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CTGF—Parkinson's disease	6.83e-06	5.23e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	6.79e-06	5.2e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF2—Parkinson's disease	6.78e-06	5.19e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	6.76e-06	5.17e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	6.73e-06	5.16e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MTHFR—Parkinson's disease	6.72e-06	5.15e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	6.67e-06	5.11e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	6.67e-06	5.11e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—INS—Parkinson's disease	6.65e-06	5.09e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EDN1—Parkinson's disease	6.6e-06	5.05e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	6.57e-06	5.03e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	6.55e-06	5.02e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	6.54e-06	5e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	6.53e-06	5e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	6.51e-06	4.98e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	6.49e-06	4.97e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EDN1—Parkinson's disease	6.48e-06	4.96e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	6.45e-06	4.94e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	6.45e-06	4.94e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CTGF—Parkinson's disease	6.44e-06	4.93e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	6.43e-06	4.93e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	6.37e-06	4.88e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—INS—Parkinson's disease	6.37e-06	4.88e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP2E1—Parkinson's disease	6.37e-06	4.87e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NQO1—Parkinson's disease	6.3e-06	4.82e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APOE—Parkinson's disease	6.26e-06	4.79e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TH—Parkinson's disease	6.21e-06	4.75e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOE—Parkinson's disease	6.08e-06	4.65e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NGF—Parkinson's disease	6.06e-06	4.64e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	6e-06	4.59e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NGF—Parkinson's disease	5.96e-06	4.57e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYCS—Parkinson's disease	5.96e-06	4.56e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NGF—Parkinson's disease	5.95e-06	4.56e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.93e-06	4.54e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NGF—Parkinson's disease	5.93e-06	4.54e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NGF—Parkinson's disease	5.91e-06	4.53e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NGF—Parkinson's disease	5.86e-06	4.48e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TH—Parkinson's disease	5.85e-06	4.48e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	5.77e-06	4.42e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	5.66e-06	4.34e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	5.65e-06	4.32e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	5.63e-06	4.31e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYCS—Parkinson's disease	5.61e-06	4.3e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	5.57e-06	4.27e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	5.56e-06	4.26e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CTGF—Parkinson's disease	5.46e-06	4.18e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOE—Parkinson's disease	5.36e-06	4.11e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—INS—Parkinson's disease	5.35e-06	4.09e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOE—Parkinson's disease	5.28e-06	4.04e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—COMT—Parkinson's disease	5.28e-06	4.04e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOE—Parkinson's disease	5.27e-06	4.03e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTP1—Parkinson's disease	5.25e-06	4.02e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOE—Parkinson's disease	5.25e-06	4.02e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CASP3—Parkinson's disease	5.24e-06	4.01e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MAOA—Parkinson's disease	5.24e-06	4.01e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOE—Parkinson's disease	5.23e-06	4.01e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—Parkinson's disease	5.21e-06	3.99e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—INS—Parkinson's disease	5.19e-06	3.97e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOE—Parkinson's disease	5.18e-06	3.97e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—HMOX1—Parkinson's disease	5.18e-06	3.96e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	5.08e-06	3.89e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NQO1—Parkinson's disease	5.03e-06	3.85e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—COMT—Parkinson's disease	4.97e-06	3.81e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TH—Parkinson's disease	4.95e-06	3.79e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	4.95e-06	3.79e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.95e-06	3.79e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.94e-06	3.78e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	4.92e-06	3.77e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.88e-06	3.74e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTM1—Parkinson's disease	4.83e-06	3.69e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	4.82e-06	3.69e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYCS—Parkinson's disease	4.76e-06	3.64e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	4.74e-06	3.63e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	4.71e-06	3.61e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4.68e-06	3.59e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GPX1—Parkinson's disease	4.62e-06	3.54e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—INS—Parkinson's disease	4.58e-06	3.51e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	4.55e-06	3.48e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTM1—Parkinson's disease	4.55e-06	3.48e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—INS—Parkinson's disease	4.51e-06	3.45e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—INS—Parkinson's disease	4.5e-06	3.44e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—INS—Parkinson's disease	4.48e-06	3.43e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—INS—Parkinson's disease	4.47e-06	3.42e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—INS—Parkinson's disease	4.43e-06	3.39e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	4.36e-06	3.34e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GPX1—Parkinson's disease	4.36e-06	3.33e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—Parkinson's disease	4.27e-06	3.27e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—COMT—Parkinson's disease	4.21e-06	3.22e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTP1—Parkinson's disease	4.19e-06	3.21e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MAOA—Parkinson's disease	4.18e-06	3.2e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HMOX1—Parkinson's disease	4.13e-06	3.17e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—Parkinson's disease	4.02e-06	3.08e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—Parkinson's disease	3.97e-06	3.04e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ABCB1—Parkinson's disease	3.97e-06	3.04e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.87e-06	2.96e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTM1—Parkinson's disease	3.85e-06	2.95e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.84e-06	2.94e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—Parkinson's disease	3.74e-06	2.86e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GPX1—Parkinson's disease	3.69e-06	2.82e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	3.55e-06	2.72e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CASP3—Parkinson's disease	3.41e-06	2.61e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—Parkinson's disease	3.4e-06	2.61e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—INS—Parkinson's disease	3.39e-06	2.6e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—Parkinson's disease	3.39e-06	2.59e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	3.36e-06	2.57e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CASP3—Parkinson's disease	3.35e-06	2.56e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	3.34e-06	2.56e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	3.33e-06	2.55e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	3.33e-06	2.55e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—Parkinson's disease	3.33e-06	2.55e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	3.32e-06	2.54e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	3.31e-06	2.53e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	3.3e-06	2.52e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	3.27e-06	2.51e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—INS—Parkinson's disease	3.2e-06	2.45e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—Parkinson's disease	3.17e-06	2.43e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	3.14e-06	2.4e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	3.09e-06	2.36e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	3.08e-06	2.36e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—Parkinson's disease	3.08e-06	2.36e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	3.07e-06	2.35e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	3.06e-06	2.34e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	3.03e-06	2.32e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—Parkinson's disease	2.91e-06	2.22e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—Parkinson's disease	2.78e-06	2.13e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—INS—Parkinson's disease	2.71e-06	2.07e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.27e-06	1.74e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—Parkinson's disease	2e-06	1.53e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.97e-06	1.51e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.97e-06	1.5e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—Parkinson's disease	1.96e-06	1.5e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—Parkinson's disease	1.95e-06	1.5e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.93e-06	1.48e-05	CbGpPWpGaD
